We are live on ! Find out more
ALPN

Alpine Immune Sciences Inc
ALPN

Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

41 hedge funds and large institutions have $183M invested in Alpine Immune Sciences Inc in 2015 Q2 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
41
Holders Change
+41
Holders Change %
–
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
41
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$55.6M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$24.5M
3
RCM
RA Capital Management
Massachusetts
+$11.3M
4
Jennison Associates
Jennison Associates
New York
+$8.59M
5
RSCM
Rock Springs Capital Management
Maryland
+$8.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$56.5M +$55.6M +933,103 New
Wellington Management Group
2
Wellington Management Group
Massachusetts
$24.6M +$24.5M +411,675 New
RCM
3
RA Capital Management
Massachusetts
$11.5M +$11.3M +189,316 New
RSCM
4
Rock Springs Capital Management
Maryland
$8.55M +$8.4M +141,090 New
Jennison Associates
5
Jennison Associates
New York
$8.53M +$8.59M +144,296 New
SM
6
Sabby Management
Florida
$6.51M +$6.4M +107,510 New
Goldman Sachs
7
Goldman Sachs
New York
$5.95M +$5.84M +98,129 New
Franklin Resources
8
Franklin Resources
California
$5.3M +$5.21M +87,500 New
KCM
9
Kingdon Capital Management
New York
$4.92M +$4.84M +81,250 New
MCM
10
Marsico Capital Management
Colorado
$4.54M +$4.47M +75,000 New
JP Morgan Chase
11
JP Morgan Chase
New York
$4.46M +$4.39M +73,648 New
DCM
12
Driehaus Capital Management
Illinois
$4.34M +$4.27M +71,633 New
SFM
13
Sphera Funds Management
Israel
$3.86M +$3.8M +63,750 New
Axa
14
Axa
France
$3.79M +$3.72M +62,500 New
Lord, Abbett & Co
15
Lord, Abbett & Co
New Jersey
$3.65M +$3.59M +60,204 New
LCP
16
Lamond Capital Partners
California
$3.41M +$3.35M +56,250 New
WSA
17
Wall Street Associates
California
$2.92M +$2.87M +48,100 New
GL
18
GLG LLC
New York
$2.77M +$2.73M +45,777 New
Federated Hermes
19
Federated Hermes
Pennsylvania
$2.27M +$2.23M +37,500 New
BA
20
BlackRock Advisors
Delaware
$2.01M +$1.98M +33,175 New
Fidelity Investments
21
Fidelity Investments
Massachusetts
$1.51M +$1.49M +25,000 New
PCM
22
Pentwater Capital Management
Florida
$1.51M +$1.49M +25,000 New
MIM
23
Monashee Investment Management
Massachusetts
$947K – – –
Ameriprise
24
Ameriprise
Minnesota
$947K +$931K +15,629 New
CC
25
CQS Cayman
Cayman Islands
$909K +$893K +15,000 New
1
2

ALPN Hedge Fund Activity: Q2 2015 in Review

41 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q2 2015, worth a combined $183M.

Buyers outnumbered sellers: 41 funds opened new ALPN positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $55.6M.

  • 41 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q2 2015, up from 0 in Q1 2015.
  • Funds reported $183M of Alpine Immune Sciences Inc stock for Q2 2015.
  • 41 funds opened new Alpine Immune Sciences Inc positions in Q2 2015 and 0 closed out, a net change of +41 holders.
  • The largest Alpine Immune Sciences Inc buyer in Q2 2015 was Deerfield Management, an estimated $55.6M added.

Based on aggregated 13F filings for Q2 2015.